Association between PSCA mRNA expression levels and rs2294008 polymorphism in transitional cell cancer of the bladder

Zheng,Kewen; Chen,Zhigang; Tian,Ye; Hao,Gangyue

doi:10.3892/ol.2014.2734

Association between PSCA mRNA expression levels and rs2294008 polymorphism in transitional cell cancer of the bladder

Authors:
- Kewen Zheng
- Zhigang Chen
- Ye Tian
- Gangyue Hao
View Affiliations

Affiliations: Department of Urology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, P.R. China
Published online on: November 24, 2014 https://doi.org/10.3892/ol.2014.2734
Pages: 557-562
Copyright: © Zheng et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Prostate stem cell antigen (PSCA) was originally identified as a gene that is overexpressed in prostate cancer, and correlates with prostate cancer progression and prognosis. Recently, a significant association has been identified between the PSCA rs2294008 (C>T) polymorphism and the risk of developing bladder cancer. Therefore, the present study investigated the different expression levels of PSCA mRNA in transitional cell carcinoma (TCC) of the bladder and normal bladder tissue. Furthermore, the association between PSCA mRNA expression levels in TCC and different rs2294008 (C>T) genotypes and various clinicopathological features, including tumor stage and grade, were evaluated. Reverse transcription‑quantitative polymerase chain reaction was performed on 80 TCC samples and 38 samples of normal bladder urothelium from TCC patients who underwent transurethral resection of bladder tumor or radical cystectomy at the Beijing Friendship Hospital (Beijing, China) between September 2010 and May 2011. Genomic DNA was extracted from tumor tissue and sequenced to determine the rs2294008 (C>T) genotype. PSCA mRNA expression was detected in all samples (100%); however, tumor samples exhibited significantly higher PSCA expression levels compared with the normal urothelium samples (P=0.038). PSCA mRNA expression was positively correlated with the histological grade of the tumor (G1‑2 vs. G3; P=0.001); however, no significant difference was detected between patients with superficial (Ta or T1) and muscle‑invasive (≥pT2) tumors (P=0.250). Thus, PSCA mRNA expression levels were associated with TCC and tumor histological grade, but not the tumor stage. Additionally, PSCA mRNA expression levels were significantly higher in T allele carriers compared with CC homozygous patients (P=0.001), indicating that the presence of the T allele may increase PSCA mRNA expression. Therefore, rs2294008 (C>T) may be associated with the biological properties of TCC and, thus, future research should focus on the physiological function of PSCA and the mechanism of rs2294008.

View Figures

View References

1	Jemal A, Siegel R, Ward E, et al: Cancer statistics, 2008. CA Cancer J Clin. 58:71–96. 2008. View Article : Google Scholar : PubMed/NCBI
2	Jemal A, Murray T, Ward E, et al: Cancer statistics, 2005. CA Cancer J Clin. 55:10–30. 2005. View Article : Google Scholar : PubMed/NCBI
3	Corral R, Lewinger JP, Van Den Berg D, et al: Comprehensive analyses of DNA repair pathways, smoking, and bladder cancer risk in Los Angeles and Shanghai. Int J Cancer. 135:335–347. 2014. View Article : Google Scholar : PubMed/NCBI
4	Wu X, Ye Y, Kiemeney LA, et al: Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer. Nat Genet. 41:991–995. 2009. View Article : Google Scholar : PubMed/NCBI
5	Ma Z, Hu Q, Chen Z, et al: Systematic evaluation of bladder cancer risk-associated single-nucleotide polymorphisms in a Chinese population. Mol Carcinog. 52:916–921. 2013. View Article : Google Scholar
6	Elsamman E, Fukumori T, Kasai T, et al: Prostate stem cell antigen predicts tumour recurrence in superficial transitional cell carcinoma of the urinary bladder. BJU Int. 97:1202–1207. 2006. View Article : Google Scholar : PubMed/NCBI
7	Yang X, Guo Z, Liu Y, et al: Prostate stem cell antigen and cancer risk, mechanisms and therapeutic implications. Expert Rev Anticancer Ther. 14:31–37. 2014. View Article : Google Scholar
8	Marra E, Uva P, Viti V, et al: Growth delay of human bladder cancer cells by Prostate Stem Cell Antigen downregulation is associated with activation of immune signaling pathways. BMC Cancer. 10:1292010. View Article : Google Scholar : PubMed/NCBI
9	Saeki N, Gu J, Yoshida T and Wu X: Prostate stem cell antigen: a Jekyll and Hyde molecule? Clin Cancer Res. 16:3533–3538. 2010. View Article : Google Scholar : PubMed/NCBI
10	Lam JS, Yamashiro J, Shintaku IP, et al: Prostate stem cell antigen is overexpressed in prostate cancer metastases. Clin Cancer Res. 11:2591–2596. 2005. View Article : Google Scholar : PubMed/NCBI
11	Cheng F, Yu W, Zhang X and Ruan Y: Quantum-dot-based technology for sensitive and stable detection of prostate stem cell antigen expression in human transitional cell carcinoma. Int J Biol Markers. 24:271–276. 2009.
12	Study Group of Millennium Genome Project for Cancer. Sakamoto H, Yoshimura K, Saeki N, et al: Genetic variation in PSCA is associated with susceptibility to diffuse-type gastric cancer. Nat Genet. 40:730–740. 2008. View Article : Google Scholar : PubMed/NCBI
13	Fu YP, Kohaar I, Rothman N, et al: Common genetic variants in the PSCA gene influence gene expression and bladder cancer risk. Proc Natl Acad Sci USA. 109:4974–4979. 2012. View Article : Google Scholar : PubMed/NCBI
14	Sobin LH, Gospodariwicz M and Wittekind C: TNM Classification of Malignant Tumors. UICC International Union Against Cancer. 7th edition. Wiley-Blackwell; Hoboken, NJ: pp. 262–265. 2005
15	Sauter G, Algaba F, Amin M, et al: Tumours of the urinary system: non-invasive urothelial neoplasias. WHO Classification of Tumours: Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. Eble JN, Sauter G, Epstein JI and Sesterhenn I: IARCC Press; Lyon: 2004
16	Chini V, Foka A, Dimitracopoulos G and Spiliopoulou I: Absolute and relative real-time PCR in the quantification of tst gene expression among methicillin-resistant Staphylococcus aureus: evaluation by two mathematical models. Lett Appl Microbiol. 45:479–484. 2007. View Article : Google Scholar : PubMed/NCBI
17	Barbisan F, Mazzucchelli R, Santinelli A, et al: Expression of prostate stem cell antigen in high-grade prostatic intraepithelial neoplasia and prostate cancer. Histopathology. 57:572–579. 2010. View Article : Google Scholar : PubMed/NCBI
18	Yagn WB, Cai F, Cheng CT, et al: Expression of prostate stem cell antigen and Claudin-4 in human pancreatic carcinoma. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 30:728–731. 2008.(In Chinese).
19	Antonarakis ES, Carducci MA, Eisenberger MA, et al: Phase I rapid dose-escalation study of AGS-1C4D4, a human anti-PSCA (prostate stem cell antigen) monoclonal antibody, in patients with castration-resistant prostate cancer: a PCCTC trial. Cancer Chemother Pharmacol. 69:763–771. 2012. View Article : Google Scholar
20	Krupa M, Canamero M, Gomez CE, Najera JL, Gil J and Esteban M: Immunization with recombinant DNA and modified vaccinia virus Ankara (MVA) vectors delivering PSCA and STEAP1 antigens inhibits prostate cancer progression. Vaccine. 29:1504–1513. 2011. View Article : Google Scholar
21	Kohaar I, Porter-Gill P, Lenz P, et al: Genetic variant as a selection marker for anti-prostate stem cell antigen immunotherapy of bladder cancer. J Natl Cancer Inst. 105:69–73. 2013. View Article : Google Scholar :
22	Sala N, Muñoz X, Travier N, et al: Prostate stem-cell antigen gene is associated with diffuse and intestinal gastric cancer in Caucasians: results from the EPIC-EURGAST study. Int J Cancer. 130:2417–2427. 2012. View Article : Google Scholar
23	Cheng L, Reiter RE, Jin Y, et al: Immunocytochemical analysis of prostate stem cell antigen as adjunct marker for detection of urothelial transitional cell carcinoma in voided urine specimens. J Urol. 169:2094–2100. 2003. View Article : Google Scholar : PubMed/NCBI
24	Kiemeney LA, Thorlacius S, Sulem P, et al: Sequence variant on 8q24 confers susceptibility to urinary bladder cancer. Nat Genet. 40:1307–1312. 2008. View Article : Google Scholar : PubMed/NCBI
25	Rothman N, Garcia-Closas M, Chatterjee N, et al: A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci. Nat Genet. 42:978–984. 2010. View Article : Google Scholar : PubMed/NCBI
26	Amara N, Palapattu GS, Schrage M, et al: Prostate stem cell antigen is overexpressed in human transitional cell carcinoma. Cancer Res. 61:4660–4665. 2001.PubMed/NCBI
27	Bahrenberg G, Brauers A, Joost HG and Jakse G: Reduced expression of PSCA, a member of the LY-6 family of cell surface antigens, in bladder, esophagus, and stomach tumors. Biochem Biophys Res Commun. 275:783–788. 2000. View Article : Google Scholar : PubMed/NCBI